TRCT
HARP

Tower Research Capital (TRC)’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Tower Research Capital (TRC)’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-706
Closed -$2.85K – 6395
2023
Q3 		$2.85K Sell
706
-641
-48% -$4.75K ﹤0.01% 5094
2023
Q2 		$9.56K Buy
1,347
+324
+32% +$2.24K ﹤0.01% 4255
2023
Q1 		$8K Sell
1,023
-366
-26% -$3.08K ﹤0.01% 4697
2022
Q4 		$10K Buy
1,389
+842
+154% +$7.09K ﹤0.01% 4132
2022
Q3 		$6K Buy
547
+29
+6% +$541 ﹤0.01% 5095
2022
Q2 		$9K Buy
518
+306
+144% +$7.92K ﹤0.01% 4621
2022
Q1 		$11K Sell
212
-70
-25% -$3.63K ﹤0.01% 4242
2021
Q4 		$21K Sell
282
-1,391
-83% -$94.9K ﹤0.01% 3636
2021
Q3 		$132K Buy
1,673
+1,451
+654% +$146K ﹤0.01% 2166
2021
Q2 		$31K Buy
222
+126
+131% +$24K ﹤0.01% 3472
2021
Q1 		$20K Sell
96
-441
-82% -$88.4K ﹤0.01% 3899
2020
Q4 		$90K Sell
537
-507
-49% -$78.3K ﹤0.01% 2456
2020
Q3 		$177K Buy
1,044
+885
+557% +$128K ﹤0.01% 2684
2020
Q2 		$26K Buy
+159
New +$24.8K ﹤0.01% 3549
2020
Q1 		– Sell
-177
Closed -$26K – 4153
2019
Q4 		$26K Sell
177
-15
-8% -$2.27K ﹤0.01% 1769
2019
Q3 		$26K Buy
+192
New +$27K ﹤0.01% 2305
2019
Q2 		– Sell
-6
Closed -$1K – 4488
2019
Q1 		$1K Buy
+6
New +$789 ﹤0.01% 3659

Other funds holding HARP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Tower Research Capital (TRC)'s HARP Position: Q4 2023 in Review

Tower Research Capital (TRC) sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q4 2023, closing a stake of 706 shares — an estimated $2.85K sold.

Tower Research Capital (TRC) first reported a position in HARP in Q1 2019 and held it in 17 quarters. The position peaked at $177K in Q3 2020. 41 funds tracked by Wall St. Rank hold HARP as of Q4 2023.

  • Tower Research Capital (TRC) reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 706 Harpoon Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $2.85K.
  • Tower Research Capital (TRC) first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2019 and held it in 17 quarters.
  • Tower Research Capital (TRC)'s Harpoon Therapeutics, Inc. Common Stock position peaked at $177K in Q3 2020.
  • 41 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.